Literature DB >> 30950331

Venous thromboembolism: A clinician update.

Maya Serhal1, Geoffrey D Barnes2.   

Abstract

Venous thromboembolism (VTE) is a common vascular condition. New medications are available to prevent hospital-associated VTE. Strategies are being studied to increase appropriate diagnostic testing utilization. Management of deep vein thrombosis (DVT) and pulmonary embolism (PE) has evolved with the advent of new anticoagulant options and catheter-directed intervention. In light of this, providers are commonly challenged with the decision regarding inpatient versus outpatient management. Which patients require long-term (> 3 months) anticoagulation is challenging and multiple clinical prediction models may be used to help determine the risk-benefit ratio in each patient. The management of VTE is an ongoing area of research and is rapidly evolving.

Entities:  

Keywords:  acute management of VTE; deep vein thrombosis (DVT); post-thrombotic syndrome; pulmonary embolism (PE); venous thromboembolism (VTE)

Mesh:

Substances:

Year:  2019        PMID: 30950331     DOI: 10.1177/1358863X18821159

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  8 in total

1.  Antithrombotic effects of heme-degrading and heme-binding proteins.

Authors:  Karl A Nath; Joseph P Grande; John D Belcher; Vesna D Garovic; Anthony J Croatt; Matthew L Hillestad; Michael A Barry; Meryl C Nath; Raymond F Regan; Gregory M Vercellotti
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-01-31       Impact factor: 4.733

Review 2.  Factor Xa inhibitors: critical considerations for clinical development and testing.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2021-05-15       Impact factor: 2.300

3.  Assessment of the adherence to and costs of the prophylaxis protocol for venous thromboembolism.

Authors:  Marcela Forgerini; Fabiana Rossi Varallo; Alice Rosa Alves de Oliveira; Tales Rubens de Nadai; Patrícia de Carvalho Mastroianni
Journal:  Clinics (Sao Paulo)       Date:  2019-08-19       Impact factor: 2.365

Review 4.  Direct-Acting Oral Anticoagulants and Their Reversal Agents-An Update.

Authors:  Stephanie A Kustos; Pius S Fasinu
Journal:  Medicines (Basel)       Date:  2019-10-15

5.  Associations between coagulation factor XII, coagulation factor XI, and stability of venous thromboembolism: A case-control study.

Authors:  Yan Meng; You Li; Yan-Jun Ye; Qiang Ma; Jun-Bo Zhang; Hao Qin; Yang-Yang Deng; Hong-Yan Tian
Journal:  World J Clin Cases       Date:  2022-03-26       Impact factor: 1.337

6.  Assessment of Venous Thromboembolism Awareness Among Surgical Ward Patients in Makkah, Saudi Arabia: A Cross-Sectional Study.

Authors:  Mohammed S Bosaeed; Rafal N Balubaid; Abdullah R Alharbi; Omar S Alhothali; Aseel K Haji; Hanan E Alkaabi; Renad A Miyajan
Journal:  Cureus       Date:  2022-08-11

7.  Knowledge and Awareness of Venous Thromboembolism in Intensive Care Units in Zhejiang Province, China: A Cross-Sectional Survey.

Authors:  Jing Yan; Jia Zhou; Junhai Zhen; Li Li; Zhejiang Provincial Critical Care Clinical Research Group
Journal:  Med Sci Monit       Date:  2020-06-16

8.  Safety of early orthopedic surgery in patients with intermediate/low- or low-risk pulmonary embolism.

Authors:  Ho Cheol Kim; Jin-Han Park; Jong-Min Song; Jae-Joon Hwang; Sang-Bum Hong; Yeon-Mok Oh; Sang-Do Lee; Jae Seung Lee
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 3.005

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.